These emerging drugs , including Semaglutide , Mounjaro , and Zaxig , represent a major advancement in addressing type 2 hyperglycemia and assisting with weight loss . They operate by emulating the body’s natural incretin GLP-1 , enabling to moderate blood glucose and reduce hunger . The medication has somewhat distinct properties and may be suit